Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The challenge of comorbidity in clinical trials for multiple sclerosis.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
From Bugs to Brains: the gut microbiome in neurological health
Monoclonal antibodies in MS: mechanisms of action.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Visualization of myelination in GFP-transgenic zebrafish.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Information for healthcare professionals: Rituximab
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
SigmaPharm Laboratories Products
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].

Pages